PATENT CLAIM ANALYSIS

Application Number: 15977586
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "019500"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 31):
The conjugate of  claim 30 , or a pharmaceutically acceptable salt thereof, wherein the cyclic structure is an arylene.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15959110', '12673931', '15606913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7029861037208059
- 35 USC 102 Novelty (BERT): 0.5555412121803954
- Combined Prediction Score: 0.6882416145667649
- Mean Citation Score: 320.363966
- Max Citation Score: 416.83243
- Similarity Product: 282.37766428751644

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test